Home » Topics » Infection » Coronavirus

Coronavirus
RSS

AVI Brings In $23M For Third-Generation Antisense Drugs

Nov. 16, 2005

Other News To Note

Nov. 3, 2005

Collaborations Between Biotech And Pharmaceutical Companies: Aug. 19-Oct. 19, 2005

Oct. 24, 2005

New SARS Target Discoveries;Fresh Therapeutic Approaches

Sep. 19, 2005

By Anette Breindl

Analysts: Interest In Antisense Waning, But Science Not Dead

Sep. 16, 2005

Other News To Note

Sep. 13, 2005

Other News To Note

July 20, 2005

ACE2 Receptor Is New Drug Target In SARS Lung Failure

July 13, 2005

By Sharon Kingman

Found Coronavirus Might Have Ties To Pediatric Heart Disease

Feb. 11, 2005

By Anette Breindl

Driving A Spike Through Heart Of SARS Proving Challenging

Jan. 18, 2005

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 8, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
Prokidney produces positive phase II CKD data, thunderous stock surge
BioWorld
A mixed bag of top-line phase II data prompted stellar stock results for Prokidney Corp. and its chronic kidney disease (CKD) and diabetes therapy, rilparencel....